Starbucks stock dips as supply-chain snags and CEO jet policy land ahead of earnings

Starbucks stock dips as supply-chain snags and CEO jet policy land ahead of earnings

Starbucks shares fell 0.6% to $95.72 Tuesday ahead of its fiscal first-quarter earnings report set for Wednesday morning. CEO Brian Niccol is under scrutiny as supply-chain issues persist despite new technology and system upgrades. The company also removed the $250,000 cap on Niccol’s personal use of the corporate jet after a security review. Wall Street analysts adjusted price targets as investors focus on sales and margins.
Carvana stock rises after Wells Fargo target hike, but options traders lean defensive

Carvana stock rises after Wells Fargo target hike, but options traders lean defensive

Carvana shares closed up 0.9% at $477.75 after volatile trading Tuesday. Wells Fargo raised its price target to $525, citing strong retail trends but flagged possible weather-related risks. Options trading showed a surge in put buying ahead of the Fed decision and Carvana’s Feb. 18 earnings. Implied volatility remained high, with puts outnumbering calls by nearly two to one.
28 January 2026
Constellation Energy stock closes higher as PJM data-center rule overhaul keeps power prices in focus

Constellation Energy stock closes higher as PJM data-center rule overhaul keeps power prices in focus

Constellation Energy closed up 1.2% at $288.76 Tuesday, after trading between $282.50 and $290.40. PJM Interconnection advanced a fast-track plan for data-center hookups and began talks on a government-backed “backstop” auction for new power capacity. Traders are watching natural-gas volatility and PJM/FERC policy moves. Constellation’s next earnings update is expected Feb. 17.
28 January 2026
Elevance Health stock gets hit by Medicare rate surprise — what traders watch before earnings

Elevance Health stock gets hit by Medicare rate surprise — what traders watch before earnings

Elevance Health shares fell 14.3% to $322.92 Tuesday after a Medicare Advantage rate proposal from CMS projected a net average payment increase of just 0.09%, far below Wall Street expectations. The move triggered a broader selloff in health insurer stocks. Investors are awaiting Elevance’s earnings report Wednesday for updates on pricing and costs. CMS will finalize policy milestones in late February and early April.
Roper Technologies stock (ROP) slides after weak 2026 outlook puts Deltek back in focus

Roper Technologies stock (ROP) slides after weak 2026 outlook puts Deltek back in focus

Roper Technologies shares dropped 9.7% to $369.27 in after-hours trading Tuesday after the company issued a 2026 profit and revenue forecast below Wall Street estimates and warned of continued weak demand at its Deltek unit. Stifel downgraded the stock, citing ongoing Deltek softness. Roper reported Q4 revenue up 10% to $2.06 billion and adjusted EPS of $5.21. The company projected 2026 adjusted EPS of $21.30–$21.55.
28 January 2026
Johnson & Johnson stock climbs after fresh FDA Darzalex Faspro nod — what investors watch next

Johnson & Johnson stock climbs after fresh FDA Darzalex Faspro nod — what investors watch next

Johnson & Johnson shares rose 1.3% Tuesday after the FDA approved a Darzalex Faspro combination for newly diagnosed multiple myeloma patients ineligible for stem-cell transplants. The S&P 500 closed at a record high, while healthcare stocks broadly fell after a Medicare payment proposal. The U.S. also named 15 drugs for future Medicare price negotiations, increasing pressure on big pharma.
KLA stock jumps nearly 5% as analysts lift targets ahead of Jan. 29 earnings

KLA stock jumps nearly 5% as analysts lift targets ahead of Jan. 29 earnings

KLA shares rose 4.8% to about $1,616 in after-hours trading Tuesday after Evercore ISI and Wolfe Research raised price targets ahead of Thursday’s earnings. The company projects fiscal Q2 revenue of $3.225 billion and non-GAAP EPS of $8.70, with Zacks’ consensus slightly higher. KLA warned U.S.-China trade tensions could cut sales by up to $350 million over the next five quarters.

Stock Market Today

GE Vernova stock price jumps toward $800 — what to know before Monday trade

GE Vernova stock price jumps toward $800 — what to know before Monday trade

7 February 2026
GE Vernova shares jumped 5.7% to $779.35 Friday after Baird upgraded the stock and the Dow closed above 50,000. The company’s onshore wind unit reported 1.1 GW in U.S. repower orders for 2025, a figure previously disclosed. GE Vernova also completed a $2.6 billion senior notes offering to help fund its Prolec GE stake purchase. Next earnings report is set for April 22.
Go toTop